Abstract
Endocannabinoids have been implicated in cancer. Increasing endogenous 2-arachidonoylglycerol (2-AG) by blocking its metabolism inhibits invasion of androgen-independent prostate cancer (PC-3 and DU-145) cells. Noladin ether (a stable 2-AG analog) and exogenous CB1 receptor agonists possess similar effects. Conversely, reducing endogenous 2-AG by inhibiting its synthesis or blocking its binding to CB1 receptors with antagonists increases the cell invasion. 2-AG and noladin ether decrease protein kinase A activity in these cells, indicating coupling of the CB1 receptor to downstream effectors. The results suggest that cellular 2-AG, acting through the CB1 receptor, is an endogenous inhibitor of invasive prostate cancer cells.
Original language | English (US) |
---|---|
Pages (from-to) | 8826-8830 |
Number of pages | 5 |
Journal | Cancer research |
Volume | 64 |
Issue number | 24 |
DOIs | |
State | Published - Dec 15 2004 |
ASJC Scopus subject areas
- Oncology
- Cancer Research